DDIT3 and diffuse large B-cell lymphoma: Clinical characteristics and their impact on survival of 414 diffuse large B‐cell lymphoma (DLBCL) patients treated with CHOP/R‐CHOP, then stratified by the SVM model as GCB or Non‐GCB group